News|Videos|September 15, 2026

Inside FIND-CKD: The Data Behind the Trial's 23% Risk Reduction

Fact checked by: Alex Hillenbrand

Brendan Neuen breaks down the full FIND-CKD primary and secondary endpoint data, subgroup consistency, and safety signals.

This is a deep dive into one segment of a recent episode of Kidney Compass: Navigating Clinical Trials, HCPLive's podcast co-hosted by Shikha Wadhwani, MD, and Brendan Neuen, MBBS, PhD. In this episode, Neuen steps out of his usual co-host role to join as a guest, discussing the FIND-CKD trial results he presented at ERA. The full episode also covers the glomerulonephritis subgroup analysis and pooled safety data.